These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8006923)

  • 1. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
    Andersson PE; Johansson J; Berne C; Lithell H
    J Hum Hypertens; 1994 Mar; 8(3):219-26. PubMed ID: 8006923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T; Westlie L; Daae LN
    J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD; Henderson AD; Wadsworth J; Poulter C; Gelding S; Richmond W; Sever PS; Elkeles RS
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxazosin improves insulin sensitivity in hypertensive patients.
    Kageyama S; Yamamoto J; Mimura A; Sakurai T; Ishibashi K; Aihara K; Taniguchi I; Ito K; Isogai Y
    Clin Ther; 1993; 15(5):829-37. PubMed ID: 8269449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T; Westlie L; Daae L
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers.
    Lecerof H; Bornmyr S; Lilja B; De Pedis G; Hulthén UL
    J Hypertens Suppl; 1990 Sep; 8(5):S29-33. PubMed ID: 1981074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    González Maqueda I
    Coron Artery Dis; 1994 Nov; 5(11):909-18. PubMed ID: 7719523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X).
    Fragasso G; Cattaneo N; Locatelli M; Caumo A; Pagnotta P; Piatti P; Bonini P; Chierchia SL
    G Ital Cardiol; 1998 Jun; 28(6):623-9. PubMed ID: 9672774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study.
    Lind L; Berne C; Pollare T; Lithell H
    J Hum Hypertens; 1995 Feb; 9(2):137-41. PubMed ID: 7752176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
    Sznajderman M; Chotkowska E; Peczkowska M; Sawicki M; Janaszek-Sitkowska H; Wiernikowska-Wegorek I; Galewicz A; Cybulska I
    Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade.
    Fliser D; Nowack R; Allendorf-Ostwald N; Kohl B; Hübinger A; Ritz E
    Am J Hypertens; 1993 Apr; 6(4):320-4. PubMed ID: 8099492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands.
    Hoogerbrugge N; de Groot E; de Heide LH; de Ridder MA; Birkenhägeri JC; Stijnen T; Jansen H
    Neth J Med; 2002 Oct; 60(9):354-61. PubMed ID: 12572707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tonocardin in complex treatment of diabetes mellitus concurrent with hypertension].
    Balabolkin MI; Khasanova ER; Trukhina TV; Kreminskaia VM
    Ter Arkh; 2002; 74(12):38-41. PubMed ID: 12577838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters.
    Zehetgruber M; Christ G; Gabriel H; Mundigler G; Beckmann R; Binder BR; Huber K
    Thromb Haemost; 1998 Feb; 79(2):378-82. PubMed ID: 9493594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
    Haenni A; Lithell H
    J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.